透過您的圖書館登入
IP:3.16.81.94
  • 學位論文

Thrombin 刺激肺部上皮細胞誘導介白素-8 表現經由 Gβγ2 依賴Rac 及PI3K/Akt 的活化

Thrombin Induces Interleukin-8 Expression Through Gβγ2-Dependent Rac and PI3K/Akt Activation in Human Pulmonary Epithelial Cells

指導教授 : 林建煌 陳炳常
若您是本文的作者,可授權文章由華藝線上圖書館中協助推廣。

摘要


Thrombin 為一個多功能的絲胺酸蛋白?,可從受傷的血管釋放來,為參與凝血反應重要的凝血因子。此外,它也可?生多方面的胞生理反應,其中包括調節發炎反應。根據先前研究指出,在呼吸道上皮細胞中,thrombin 可誘導前發炎物質IL-8 的產生,然而其中作用機制仍不清楚。本篇論文主要探討主題在thrombin 刺激肺部上皮細胞?生IL-8 表現是否經由Gβγ2、Rac 及PI3K/Akt 之訊息傳導而來。 在A549 肺部上皮細胞中,thrombin 誘導IL-8 的釋放呈現濃度相關反應曲線增加,並可利用轉染及報告基因的方法證實thrombin 及受體N 端合成胜?SFLLRN-NH2(PAR1 作用劑)和GYPGQV-NH2PAR4 作用劑)也可誘導IL-8-luciferase 的活性,但TFRGAP-NH2 PAR3 作用劑)卻無法增加IL-8-luciferase 的活性。接著進一步證實,thrombin 誘導IL-8 釋放及IL-8-luciferase 的活性,可被轉染dominant negative mutant of Rac (Rac N17)和PI3K 抑制劑(LY 294002)及dominant negative mutant of Akt (Akt DN)所抑制。Thrombin 具時間相性誘導Rac 及Akt 的活性,同時thrombin SFLLRN-NH2 及GYPGQV-NH2 也可誘導Akt Ser473 的磷酸化。更進一步證實,thrombin 誘導Akt Ser473 的磷酸化,可被Rac N17 及LY 294002 所抑制;同時thrombin 所誘導Akt 的激?活性,也可被Rac N17、LY 294002及Akt DN 所抑制。此外,thrombin 所誘導的IKKα/β的磷酸化可被Rac N17、LY 294002 及Akt 抑制劑所抑制;同時Rac N17、LY 294002及Akt DN 可抑制thrombin 誘導的IKKα/β的激?活性。再者RacN17、Akt DN 及LY 294002 皆可以抑制thrombin 誘導κB-luciferase的活性。最後更進一步證實thrombin 可以依時間相關性的誘導Gβγ2及Rac 與p85α的結合。綜合以上的實驗結果,可以推測出在A549肺部上皮細胞中,thrombin 可經由Gβγ2/Rac/PI3K/Akt 的路徑活化IKKα/β進一步再活化NF-κB 來調控IL-8 的表現及釋放。

關鍵字

凝血? 介白素-8 發炎及應

並列摘要


Thrombin, a multifunctional serine protease generated at sites of vascular injury, and known for its pivotal role in the coagulation cascade, contributes to tissue repair, but also promotes a wide range of cellular responses including modulation of the inflammatory responses. A previous report showed that thrombin can induce IL-8 release in human epithelial cells, however, the signal transduction is still unclear. This investigated the signaling pathway involved in Gβγ2, Rac and PI3K/Akt in IL-8 expression caused by thrombin in A549 lung epithelial cell.Thrombin caused a concentration-dependent increase in IL-8 release, which was attenuated by cell transfection with dominant negative mutant of Rac (Rac N17), LY 294002 (a PI3K inhibitor), and dominant negative mutant of Akt (Akt DN). Thrombin, SFLLRN-NH2 (a PAR1 agonist peptide), and GYPGQV-NH2 (a PAR4 agonist peptide), all induced an increase in IL-8-luciferase activity, while TFRGAP-NH2 (a PAR3 agonist peptide) had no effect. Treatment of A549 cells with thrombin caused increase in Rac and Akt activities. Similarly, SFLLRN-NH2, and GYPGQV-NH2 but not TFRGAP-NH2 inducedphosphorylation of Akt at Ser473. Pretreatment of A549 cells with LY294002 or transient transfection with Rac N17 inhibitedthrombin-induced Akt activity. In addition, Rac N17 and Akt DN inhibited thrombin-induced IKKα/β kinase activity. Moreover, Rac N17,LY 294002, and Akt DN all inhibited thrombin-induced increase in κB-luciferase activity. Further studies reveals that thrombin induced therecruitment of p85α and Rac to Gβγ2 in time-dependent manner. These results indicate that thrombin activates the Gβγ2/Rac/PI3K/Akt signaling pathway to activate IKKα/β, which in turn initiates NF-κB activation,and ultimately induces IL-8 expression and release in A549 cells.

並列關鍵字

thrombin Interleukin-8 inflammation

參考文獻


Asokananthan, N., Graham, P.T., Fink, J., Knight, D.A., Bakker, A.J.,McWilliam, A.S., Thompson, P.J. and Stewart, G.A. (2002 Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells. J. Immunol. 168, 3577-3585.
Baldwin, A.S., Jr. (1996) The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683
Bhattacharyya, S., Sen, P., Wallet, M., Long, B., Baldwin, A.S., Jr. and Tisch, R. (2004) Immunoregulation of dendritic cells by IL-10 is mediated through suppression of the PI3K/Akt pathway and of IκB kinase activity. Blood 104, 1100-1109.
Bishop, A.L. and Hall, A. (2000) Rho GTPases and their effector proteins.Biochem. J. 348 Pt 2, 241-255.
Bokoch, G.M., Vlahos, C.J., Wang, Y., Knaus, U.G. and Traynor-Kaplan,A.E. (1996) Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem. J. 315 ( Pt 3), 775-779.

延伸閱讀